Mitapivat sulfate

Mitapivat Sulfate is used to treat pyruvate kinase deficiency (PKD), a rare genetic disorder that causes chronic hemolytic anemia. It works by activating the pyruvate kinase enzyme in red blood cells, improving their energy production and lifespan. Mitapivat is also being studied for use in thalassemia and sickle cell disease. It is grouped under the following drug class(es): Sickle cell agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Pyrukynd and Mitapivat hemisulfate sesquihydrate. Its PubChem CID is 134693700.

CAS No 2151847-10-6
Molecular Formula C48H60N8O13S3
Molecular Weight 1053.20 g/mol
Synonyms bis(N-[4-[4-(cyclopropylmethyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide);sulfuric acid;trihydrate

Frequently Asked Questions